Governance, Ethics, Resilience and Sustainable Strategy

Introduction

Material and equipment management in healthcare is no longer a narrow purchasing function. It is a governance and strategy discipline concerned with patient safety, continuity of care, financial stewardship, legal compliance, environmental responsibility and public trust. A hospital may possess sophisticated clinical technology yet remain vulnerable if critical suppliers are concentrated in one region, inventory records are unreliable, procurement decisions are conflicted, or equipment maintenance is neglected.

Governance provides the structures through which authority is exercised and decisions are scrutinised. Ethics determines whether decisions are fair, transparent and consistent with professional duties. Resilience concerns the capacity of a supply system to anticipate, absorb, adapt to and recover from disruption. Sustainability extends the decision horizon beyond the purchase price to include environmental impacts, labour conditions, total life-cycle cost and intergenerational welfare.

For health-care managers, these dimensions are interdependent. A low-cost product that fails during an emergency is not economical. A donation accepted without due diligence may create disposal, maintenance or patient-safety liabilities. A supplier selected through an opaque process may expose the organisation to corruption allegations even when the product performs adequately.

Learning Objectives

By the end of this chapter, the learner should be able to:

1. Design governance structures that establish accountability and segregation of duties.
2. Apply audit, anti-corruption and conflict-of-interest controls to procurement and inventory decisions.
3. Evaluate ethical supplier relationships and responsible contracting practices.
4. Develop multi-tier supply-network resilience, emergency stock policies and business-continuity plans.
5. Integrate sustainable procurement and circular-economy principles into equipment decisions.
6. Critically assess digital technologies, artificial intelligence and emerging health-care supply models.
7. Use performance indicators and risk-based assurance to support strategic decisions.

1. Governance as an Operating System for Material Management

Governance is the system of decision rights, controls, information flows and assurance mechanisms used to direct and monitor an organisation. It differs from management: management executes plans, whereas governance determines who may decide, under what rules, with what evidence and subject to what review.

A robust governance system has five characteristics:

• Accountability: an identifiable person or committee owns each decision and outcome.
• Transparency: decisions, criteria, approvals and exceptions are documented.
• Proportionality: controls reflect the value, criticality and risk of the item.
• Independence: review is sufficiently separate from the activity being reviewed.
• Learning: incidents, near misses and audits produce corrective action rather than concealment.

1.1 A three-level governance architecture

A practical architecture contains three levels.

A materials and equipment committee should include procurement, finance, nursing, medical staff, pharmacy where relevant, biomedical engineering, infection prevention, information technology, legal/compliance and sustainability expertise. Its membership should not be dominated by one professional or supplier interest.

The committee should approve standardisation policies, high-risk technology purchases, emergency substitutions and disposal principles. It should not personally select suppliers in circumstances where individual members have undisclosed interests.

1.2 Segregation of duties

Segregation of duties reduces the possibility that one person can initiate, authorise, receive and pay for a transaction without independent scrutiny. The minimum control separates:

1. Requisition: identifying the need.
2. Approval: confirming clinical, budgetary and policy legitimacy.
3. Sourcing: obtaining and evaluating offers.
4. Receiving: verifying quantity, quality and conformity.
5. Recording: entering the transaction into the system.
6. Payment: releasing funds.
7. Review: checking exceptions and performance.

In a small facility, complete separation may be impossible. Compensating controls include secondary approval, rotation of duties, independent inventory counts, post-payment review and restricted system permissions.

1.3 The control environment and the audit trail

Controls are effective only when organisational culture supports them. Senior leaders should communicate that patient safety and integrity take priority over speed, personal relationships or arbitrary cost reduction. Every material transaction should generate an audit trail showing the request, specification, approvals, quotations or tender evidence, evaluation, purchase order, receipt, invoice, payment and any change order.

Audit should be risk-based rather than merely routine. High-risk areas include emergency purchasing, sole-source awards, contract extensions, gifts and hospitality, high-value equipment, controlled devices, inventory adjustments and suppliers with opaque ownership. Useful audit tests include matching purchase orders to receipts and invoices, examining unusual price changes, reviewing dormant suppliers and comparing authorised prices with paid prices.

2. Ethical Procurement and Anti-Corruption

Healthcare procurement has a distinctive ethical burden because decisions affect life, health and public resources. Ethical procurement requires more than compliance with a procurement law. It requires fair competition, accurate specifications, respect for human rights, confidentiality of legitimate commercial information and avoidance of decisions that create preventable patient risk.

2.1 Common integrity risks

Risks include bribery, facilitation payments, bid rigging, collusion, tailor-made specifications, undisclosed commissions, false delivery records, invoice splitting to avoid approval thresholds, inappropriate gifts, revolving-door employment and manipulation of emergency procedures. Corruption risk increases when the buyer has broad discretion, information is asymmetric, competition is weak and oversight is delayed.

A sound anti-corruption programme should include:

• a code of conduct applying to employees, contractors and agents;
• a gifts, hospitality and sponsorship register;
• due diligence on ownership, sanctions, reputation and beneficial interests;
• competitive procedures with documented exceptions;
• protected whistle-blowing channels and non-retaliation;
• investigation and disciplinary procedures;
• training based on realistic procurement scenarios; and
• monitoring of third parties and subcontractors.

Emergency procurement must be controlled, not exempt from control. A genuine emergency may justify shortened competition, but it should still require written justification, reasonable pricing evidence, authorisation, receipt verification and retrospective review.

2.2 Conflict of interest

A conflict of interest exists when a private, professional or personal interest could improperly influence official duties. A conflict is not automatically misconduct; concealment and biased action are the serious risks. A usable policy requires declaration at appointment, annual declaration, event-based updating and recusal where appropriate.

For example, a clinician who helped develop a device may provide technical information, but should not unilaterally approve its purchase if the clinician receives royalties. The committee should record the disclosure, define the individual’s permitted role and ensure independent evaluation.

2.3 Ethical supplier relations

Ethical supplier management is neither unconditional trust nor adversarial purchasing. It combines clear expectations with proportionate verification. Contracts should address product quality, traceability, regulatory conformity, cybersecurity where equipment is connected, labour standards, environmental obligations, confidentiality, incident reporting, audit rights, subcontracting and exit support.

Supplier relationships should be evaluated over the whole life cycle. A supplier that offers a low acquisition price but poor maintenance response, unavailable spare parts or frequent recalls may create greater total cost and clinical risk than a higher-priced alternative.

A balanced supplier scorecard may include quality and safety, delivery reliability, total cost, responsiveness, sustainability, ethical conduct and innovation. Weightings should be declared before evaluation and should reflect clinical criticality rather than being altered to favour a preferred bidder.

3. Resilient Health-Care Supply Networks

Resilience is the capability of a supply network to maintain or rapidly restore required service when exposed to disruption. It is different from efficiency. Efficiency often seeks minimum inventory, few suppliers and high asset utilisation; resilience values options, visibility, redundancy and recovery capacity. Strategic design must balance both.

3.1 From first-tier purchasing to multi-tier visibility

A hospital usually contracts with a distributor or manufacturer but depends on raw-material processors, component makers, sterilisation providers, transport companies, utilities and information systems. A disruption may therefore originate several tiers away. Multi-tier mapping identifies:

• critical products and approved alternatives;
• first-, second- and deeper-tier suppliers;
• geographic concentration;
• single points of failure;
• transport routes and lead times;
• regulatory dependencies;
• substitution constraints; and
• recovery and allocation priorities.

A risk register should classify items by clinical consequence, demand variability, lead time, substitutability and supply concentration. Criticality should be based on the effect of non-availability, not simply purchase value.

3.2 Resilience strategies

Important strategies include:

• Dual or multiple sourcing: reduces dependence on one supplier, although qualification and volume fragmentation may increase cost.
• Geographic diversification: reduces exposure to local disasters but may add regulatory and logistics complexity.
• Strategic inventory: buffers supply interruptions, but requires expiry and storage-capacity management.
• Substitution protocols: pre-approve clinically safe alternatives and train users.
• Supplier collaboration: share forecasts, capacity information and disruption signals.
• Local or regional capability: can shorten response time but may lack scale.
• Modular equipment and interoperability: permits replacement of components or vendors.
• Visibility technology: improves detection but does not itself create physical supply.

A resilient network is not necessarily one with the maximum number of suppliers. Excessive fragmentation can reduce quality assurance, bargaining power and data visibility. The appropriate design depends on criticality, demand, lead time, switching cost and the consequences of failure.

3.3 Emergency stock policy

Emergency stock should be governed by a policy rather than accumulated reactively. The policy should specify the protected items, target service level, minimum and maximum quantities, rotation method, ownership, release authority, replenishment trigger, expiry controls and conditions for substitution.

For an item with uncertain demand during replenishment, a commonly used cycle-service safety-stock model is:

where SS is safety stock in units, z is the standard-normal value associated with the desired cycle-service level, and σ_LT is the standard deviation of demand during lead time. This model assumes demand during lead time is approximately normally distributed, observations are representative, lead time is fixed or its variability is already incorporated, and the target concerns the probability of avoiding a stockout in one replenishment cycle.

If demand per period has standard deviation σ_d and lead time is fixed at L periods, then:

If both demand and lead time vary independently, a commonly applied approximation is:

where d̄ is average demand per period and σ_L is the standard deviation of lead time in periods. The approximation assumes independence and is less reliable when demand and lead time are correlated or distributions are highly skewed.

Worked example. A hospital uses 40 sterile kits per day. Demand standard deviation is 8 kits per day, lead time is fixed at 9 days, and management chooses a service-level factor of z = 2.05. Then:

σ_LT = 8 × √9 = 24 kits.

Therefore:

SS = 2.05 × 24 = 49.2 kits.

The hospital would hold approximately 50 safety kits, subject to packaging multiples, expiry, storage capacity and clinical validation. This result is not a guarantee against stockout; it is a statistical target under the stated assumptions.

Emergency stock can also be positioned at multiple locations. Central stock offers scale and control; decentralised stock improves access but may be harder to monitor. Rotation through normal consumption, expiry alerts and periodic physical verification are essential.

3.4 Business-continuity planning

A business-continuity plan translates risk analysis into action. It should identify essential services, maximum tolerable downtime, minimum service levels, dependencies, recovery priorities, responsible roles, communication routes and alternate operating procedures. Plans should address supply interruption, cyberattack, power failure, flooding, epidemic demand, equipment failure, workforce shortage and transport disruption.

A continuity cycle consists of:

1. business-impact analysis;
2. risk assessment;
3. prevention and preparedness;
4. response and escalation;
5. continuity or workaround operations;
6. recovery and restoration; and
7. post-incident learning.

Exercises are more valuable than documents alone. Tabletop simulations can test decision rights, stock-release rules and supplier communication. Functional exercises can test alternate receiving, manual documentation and equipment substitution. After-action reviews should assign owners and deadlines for corrective actions.

4. Sustainable and Circular Material Management

Sustainable procurement considers environmental, social and economic value across the life cycle. It asks not only “What is the purchase price?” but also “What resources, emissions, risks, labour conditions, waste and future liabilities are associated with this decision?”

4.1 Life-cycle thinking

Life-cycle cost may include acquisition, delivery, installation, training, energy, consumables, maintenance, downtime, software licences, compliance, decommissioning and disposal. A simplified present-value model is:

where C₀ is initial cost, C_t is cost in period t, r is the discount rate per period, S_n is residual or salvage value at period n, and n is the analysis horizon. All monetary values must be expressed in the same currency and price basis. The model assumes future costs and residual value can be estimated and that the selected discount rate is appropriate to the organisation’s policy. It excludes non-monetised benefits unless they are separately assessed.

Environmental assessment may consider energy use, water, packaging, transport, hazardous substances, emissions and end-of-life treatment. Organisations should avoid unsupported claims such as “green” or “carbon neutral” and require evidence, recognised standards or supplier-specific data.

4.2 Circular approaches

A linear model extracts resources, manufactures products, uses them and discards them. A circular approach seeks to preserve value through reduction, reuse, repair, refurbishment, remanufacturing and recycling, in that order where clinically safe.

Healthcare imposes limits. Sterility, infection prevention, biocompatibility, calibration, cybersecurity and regulatory requirements may prohibit reuse or reprocessing for some products. Circularity must never override patient safety. Appropriate actions include reusable alternatives where validated, repairable equipment, modular components, take-back agreements, refurbishment by qualified providers, recyclable packaging and segregation of clinical and non-clinical waste.

4.3 Sustainable procurement criteria

Tender documents can include mandatory and scored criteria such as energy efficiency, repairability, availability of spare parts, product durability, packaging reduction, supplier labour standards, emissions disclosure, take-back arrangements and disposal instructions. Criteria should be relevant, measurable, verifiable and proportionate. Sustainability requirements that are impossible for small suppliers to meet may unintentionally reduce competition; phased requirements and equivalent evidence can improve inclusion.

5. Digital Technologies, AI and Future Supply Models

Digital systems can strengthen governance through traceability, demand forecasting, condition monitoring, electronic catalogues and automated alerts. Radio-frequency identification, barcoding and Internet-connected sensors may improve inventory accuracy and temperature monitoring. Digital twins and scenario models can test network disruption before it occurs.

Artificial intelligence can support demand forecasting, anomaly detection, supplier-risk screening and preventive maintenance. However, AI does not remove managerial accountability. Risks include biased training data, opaque recommendations, false confidence, privacy breaches, cyberattack and automation of inaccurate master data. Human review is required for high-consequence decisions, particularly substitutions, allocation during shortages and equipment failure predictions.

Good technology governance requires:

• a documented purpose and decision owner;
• validated data definitions and master data;
• access control and segregation of system privileges;
• audit logs and change management;
• cybersecurity and incident response;
• model validation, performance monitoring and bias testing;
• vendor exit and data-portability provisions; and
• a manual fallback process.

Future models may include regional pooled procurement, shared equipment platforms, outcome-based contracts, supplier-managed inventory, additive manufacturing for selected parts, and predictive service contracts. These models can improve flexibility, but they may also create dependency, intellectual-property constraints, data-sharing concerns and unclear liability. Strategic evaluation should compare clinical value, resilience, total cost, sustainability, governance and reversibility—not novelty alone.

6. Performance Measurement and Strategic Assurance

A governance system requires indicators that reveal both results and control health. Possible measures include:

Indicators should have a defined owner, data source, frequency, target, tolerance and escalation rule. A low stockout rate achieved by excessive inventory is not necessarily excellent performance. Balanced measurement prevents one-dimensional optimisation.

Illustrative Case: Regional Hospital Network During a Sterile-Glove Disruption

Background

A fictional regional hospital network operated four hospitals and purchased 85% of its sterile surgical gloves from one distributor. The contract had been selected primarily on unit price. Inventory records were generally accurate, but the network had no formal second-source qualification, no tier-two visibility and no agreed substitution protocol.

Problem

A manufacturing interruption caused the distributor to ration deliveries. Surgical departments reported shortages within ten days. Emergency purchasing began, prices rose sharply and clinicians ordered different glove types independently. The network faced cancellation of procedures, inconsistent sizes and increased risk of undocumented substitutions.

Analysis

A rapid review identified four failures: concentration risk had not been measured; the emergency stock target had no clinical basis; purchasing and clinical approval were not coordinated; and the contract lacked disruption-notification and allocation clauses. A conflict-of-interest review also found that one evaluation-panel member had previously consulted for a competing manufacturer, although no evidence showed that the person had influenced the original award.

Approach and solution

The chief operating officer formed a cross-functional incident team. It classified glove types by procedure and clinical requirement, validated two alternative products, and created a controlled substitution matrix. Existing stock was pooled and allocated according to procedure criticality. A temporary emergency purchase was approved with documented price benchmarking and retrospective audit.

For the next contract, the network used dual sourcing, minimum supplier-capacity evidence, disruption-notification requirements and a take-back arrangement for excess packaging. It established a rotating emergency reserve, expiry monitoring and quarterly supplier-risk review. The conflicted panel member was recused from the re-tender and the disclosure was recorded.

Outcome

The network avoided cancellation of emergency procedures and restored stable supply after six weeks. The second-source arrangement increased the annual purchase cost by 3%, but the board judged this acceptable because it reduced concentration risk and improved recovery capability. The reserve policy reduced uncertainty without creating excessive obsolete stock.

Learning points

The case demonstrates that resilience is designed before disruption, not improvised during it. Price-only evaluation ignored clinical consequences and switching costs. Governance enabled rapid action because authority, evidence requirements and escalation routes were defined. Finally, disclosure and recusal protected the legitimacy of the procurement process even in the absence of proven misconduct.

Challenges and Limitations

Governance can become bureaucratic if every low-risk purchase receives the same approval burden. Risk-based controls are therefore preferable to universal escalation. Multiple sourcing may increase cost, reduce volume discounts and complicate quality assurance. Emergency reserves may expire, especially for products with short shelf lives. Sustainability metrics may be incomplete or incomparable across suppliers. Digital systems can amplify inaccurate records and create new cyber dependencies. AI forecasts may fail during unprecedented events because historical data no longer represent the operating environment.

Ethical tensions also require judgement. Local procurement may support community resilience but cost more. Reuse may reduce waste but increase infection-control risk. Supplier transparency may conflict with legitimate commercial confidentiality. During shortages, allocating scarce products fairly may require limiting discretionary use, and such decisions should be based on transparent clinical and ethical criteria rather than purchasing power alone.

Best-Practice Design Checklist

A mature health-care material-management system should:

1. Map decision rights and segregate incompatible duties.
2. Maintain current policies for conflicts, gifts, emergency purchasing and whistle-blowing.
3. Link criticality assessment to inventory, sourcing and continuity decisions.
4. Maintain validated alternatives for clinically important products.
5. Use contracts that address quality, traceability, continuity, data, sustainability and exit.
6. Audit high-risk transactions and close findings with named owners.
7. Apply life-cycle costing and circular principles without compromising patient safety.
8. Validate digital tools and retain human accountability.
9. Exercise continuity plans and document lessons learned.
10. Report balanced indicators to executive and board-level governance.

Chapter Summary

Governance establishes who may decide, how decisions are documented and how performance is challenged. Effective material and equipment governance depends on accountability, segregation of duties, risk-based audit, conflict-of-interest management and ethical supplier relationships. Anti-corruption systems must cover ordinary and emergency procurement, while supplier contracts should address quality, continuity, labour, environmental and technology risks.

Resilient supply networks use multi-tier visibility, qualified alternatives, strategic inventory, substitution protocols, geographic and supplier diversification, and tested business-continuity plans. Safety-stock calculations can support emergency policy, but their assumptions and data limitations must be understood. Sustainable strategy requires life-cycle costing, measurable environmental and social criteria, and circular practices that remain subordinate to clinical safety. Digital technologies and AI can improve visibility and prediction, but they introduce cyber, privacy, bias and accountability risks. The strategic objective is not minimum cost alone; it is dependable, ethical, sustainable and clinically safe value over the asset and supply life cycle.

Key Terms

Governance: The system by which authority, accountability and oversight are exercised.

Segregation of duties: Separation of incompatible transaction responsibilities among different people or roles.

Audit trail: Documented evidence showing the sequence and authorisation of a transaction.

Conflict of interest: A situation in which private interests could improperly influence official duties.

Beneficial ownership: The natural person or persons who ultimately control or benefit from an organisation.

Emergency procurement: Accelerated purchasing justified by an immediate and documented operational need.

Supply-chain resilience: The capacity to anticipate, absorb, adapt to and recover from disruption.

Multi-tier visibility: Understanding dependencies beyond the immediate supplier.

Criticality: The consequence of failure or non-availability of an item or service.

Safety stock: Inventory held to protect against demand or lead-time uncertainty.

Service level: A defined probability or performance target for meeting demand without shortage.

Business-impact analysis: Assessment of how disruption affects essential activities and recovery priorities.

Business continuity: The capability to maintain or restore essential operations during disruption.

Life-cycle cost: Total cost incurred across acquisition, use, maintenance and end of life.

Circular economy: An approach that preserves product and material value through reduction, reuse, repair and recovery.

Supplier due diligence: Investigation of a supplier’s capacity, ownership, integrity and compliance.

Total cost of ownership: The comprehensive cost of acquiring, operating and disposing of an asset.

Preventive maintenance: Planned maintenance performed to reduce the probability of failure.

Responsible procurement: Purchasing that integrates ethical, social, environmental and economic considerations.

Model governance: Controls for the validation, use, monitoring and accountability of analytical or AI models.

Review Questions

Short Answer Questions

1. What is the difference between governance and management in material and equipment management?
2. Why is segregation of duties important in procurement?
3. Define a conflict of interest and state two appropriate controls.
4. What is meant by multi-tier supply-chain visibility?
5. List four elements that should appear in an emergency stock policy.

Long Answer Questions

1. Explain how a health-care organisation can design a governance architecture for high-value equipment procurement.
2. Discuss the principal anti-corruption risks in health-care procurement and the controls required to manage them.
3. Explain how resilience and efficiency may conflict in supply-network design. How should managers balance them?
4. Discuss life-cycle costing and circular-economy principles in relation to medical equipment.
5. Evaluate the opportunities and risks of using AI for demand forecasting and predictive maintenance.

Analytical / Application Questions

1. A hospital has one supplier for a critical implant, a 12-week lead time and no approved alternative. Construct a risk-reduction plan covering governance, sourcing, inventory and continuity.
2. Using the safety-stock assumptions in this chapter, calculate safety stock when daily demand standard deviation is 6 units, fixed lead time is 16 days and z = 1.65. Explain the limitations of your answer.
3. A supplier offers the lowest price but has poor labour transparency, high equipment energy consumption and no take-back programme. Develop a weighted evaluation approach and justify the criteria you would use.

Multiple Choice Questions with Answers

Question 1

Which activity should normally be independent of supplier selection?

A. Defining the clinical need

B. Evaluating technical conformity

C. Authorising payment

D. Preparing a product specification

Correct Answer: C. Authorising payment

Question 2

A conflict of interest becomes especially problematic when an individual:

A. Has professional expertise

B. Discloses the interest and recuses themselves

C. Receives training from a supplier

D. Conceals the interest and influences the decision

Correct Answer: D. Conceals the interest and influences the decision

Question 3

Which strategy most directly reduces dependence on a single supplier?

A. Dual sourcing

B. Reducing cycle counts

C. Extending payment terms

D. Removing emergency stock

Correct Answer: A. Dual sourcing

Question 4

If daily demand standard deviation is 5 units, fixed lead time is 4 days and z = 2, what is safety stock using SS = z × σd × √L?

A. 10 units

B. 20 units

C. 40 units

D. 50 units

Correct Answer: B. 20 units

Question 5

Which statement about emergency procurement is most accurate?

A. It requires no documentation

B. It should be subject to retrospective review

C. It eliminates the need for receipt verification

D. It permits undisclosed commissions

Correct Answer: B. It should be subject to retrospective review

Question 6

Which is an example of a circular-economy practice?

A. Disposing of usable equipment immediately

B. Purchasing without considering maintenance

C. Refurbishing equipment through a qualified provider

D. Selecting the product with the largest packaging volume

Correct Answer: C. Refurbishing equipment through a qualified provider

Question 7

What is a key limitation of AI-based supply forecasting during an unprecedented disruption?

A. It always prevents stockouts

B. Historical data may not represent the new conditions

C. It removes the need for human accountability

D. It cannot process any operational data

Correct Answer: B. Historical data may not represent the new conditions

Question 8

Which item is most appropriate for a risk-based audit?

A. A routine low-value stationery purchase with complete documentation

B. A sole-source emergency purchase with a large price variance

C. A published inventory policy

D. A completed staff training record

Correct Answer: B. A sole-source emergency purchase with a large price variance

Question 9

Life-cycle cost includes which combination?

A. Purchase price only

B. Purchase price and advertising only

C. Acquisition, operation, maintenance and end-of-life costs

D. Supplier profit and tax revenue only

Correct Answer: C. Acquisition, operation, maintenance and end-of-life costs

Question 10

Why should a business-continuity plan be exercised?

A. To replace all written procedures

B. To test roles, assumptions and recovery actions

C. To increase supplier prices

D. To avoid documenting incidents

Correct Answer: B. To test roles, assumptions and recovery actions